Viemed Healthcare, Inc. (VMD)
USD 6.85
(-3.11%)
USD 6.85
(-3.11%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 40.79 Million USD | 104.47% |
| 2022 | 19.94 Million USD | -13.8% |
| 2021 | 23.14 Million USD | -25.03% |
| 2020 | 30.86 Million USD | -20.64% |
| 2019 | 38.89 Million USD | 110.35% |
| 2018 | 18.49 Million USD | 32.59% |
| 2017 | 13.94 Million USD | 18.2% |
| 2016 | 11.79 Million USD | 9.65% |
| 2015 | 10.76 Million USD | 526.73% |
| 2014 | 1.71 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 38.6 Million USD | -5.36% |
| 2024 Q2 | 42.76 Million USD | 10.79% |
| 2023 Q2 | 44.61 Million USD | 81.4% |
| 2023 Q3 | 40.58 Million USD | -9.02% |
| 2023 FY | 40.79 Million USD | 104.47% |
| 2023 Q1 | 24.59 Million USD | 23.28% |
| 2023 Q4 | 40.79 Million USD | 0.5% |
| 2022 Q4 | 19.94 Million USD | -21.8% |
| 2022 FY | 19.94 Million USD | -13.8% |
| 2022 Q1 | 22.96 Million USD | -0.77% |
| 2022 Q2 | 22.67 Million USD | -1.25% |
| 2022 Q3 | 25.51 Million USD | 12.49% |
| 2021 Q3 | 26.11 Million USD | 5.49% |
| 2021 Q4 | 23.14 Million USD | -11.37% |
| 2021 FY | 23.14 Million USD | -25.03% |
| 2021 Q1 | 29.58 Million USD | -4.17% |
| 2021 Q2 | 24.75 Million USD | -16.33% |
| 2020 FY | 30.86 Million USD | -20.64% |
| 2020 Q4 | 30.86 Million USD | -20.39% |
| 2020 Q3 | 38.77 Million USD | -5.55% |
| 2020 Q2 | 41.05 Million USD | 8.01% |
| 2020 Q1 | 38 Million USD | -2.29% |
| 2019 Q1 | 22.03 Million USD | 19.15% |
| 2019 Q4 | 38.89 Million USD | 7.16% |
| 2019 Q2 | 31.59 Million USD | 43.4% |
| 2019 Q3 | 36.29 Million USD | 14.87% |
| 2019 FY | 38.89 Million USD | 110.35% |
| 2018 Q2 | 14.49 Million USD | 4.1% |
| 2018 FY | 18.49 Million USD | 32.59% |
| 2018 Q1 | 13.92 Million USD | -0.19% |
| 2018 Q3 | 16.37 Million USD | 12.97% |
| 2018 Q4 | 18.49 Million USD | 12.96% |
| 2017 Q3 | 11.65 Million USD | 0.0% |
| 2017 Q1 | - USD | -100.0% |
| 2017 FY | 13.94 Million USD | 18.2% |
| 2017 Q4 | 13.94 Million USD | 19.63% |
| 2016 Q4 | 11.79 Million USD | 0.0% |
| 2016 FY | 11.79 Million USD | 9.65% |
| 2015 FY | 10.76 Million USD | 526.73% |
| 2014 FY | 1.71 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 20.416% |
| BrainsWay Ltd. | 15.31 Million USD | -166.359% |
| Cerus Corporation | 144.3 Million USD | 71.733% |
| Envoy Medical, Inc. | 9.4 Million USD | -333.846% |
| electroCore, Inc. | 8.94 Million USD | -356.012% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -663.576% |
| IceCure Medical Ltd | 4.24 Million USD | -860.448% |
| Inogen, Inc. | 121.38 Million USD | 66.395% |
| OrthoPediatrics Corp. | 72.56 Million USD | 43.785% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -37.893% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -1181.928% |
| MaxCyte, Inc. | 36.1 Million USD | -12.97% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -2107.371% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -9491.36% |
| Orthofix Medical Inc. | 326.58 Million USD | 87.51% |
| PAVmed Inc | 57.13 Million USD | 28.61% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -60.194% |
| RxSight, Inc. | 22.18 Million USD | -83.839% |
| Sight Sciences, Inc. | 46.43 Million USD | 12.158% |
| SI-BONE, Inc. | 61.05 Million USD | 33.186% |
| TELA Bio, Inc. | 59.16 Million USD | 31.059% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 64.209% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -295.292% |
| Acutus Medical, Inc. | 54.83 Million USD | 25.618% |
| Talis Biomedical Corporation | 29.22 Million USD | -39.578% |
| Spectral AI, Inc. | 12.4 Million USD | -228.927% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -76.322% |
| CVRx, Inc. | 39.28 Million USD | -3.839% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -241.11% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -1579.094% |
| Bioventus Inc. | 589.79 Million USD | 93.084% |
| Venus Concept Inc. | 107.1 Million USD | 61.915% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 21.046% |
| LivaNova PLC | 1.15 Billion USD | 96.459% |
| 908 Devices Inc. | 37.49 Million USD | -8.803% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 94.202% |
| Nemaura Medical Inc. | 26.37 Million USD | -54.641% |
| NeuroPace, Inc. | 86.99 Million USD | 53.113% |
| LENSAR, Inc. | 22.4 Million USD | -82.026% |
| Apyx Medical Corporation | 52.31 Million USD | 22.034% |
| Cutera, Inc. | 518.12 Million USD | 92.127% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -39.083% |
| BioSig Technologies, Inc. | 4.68 Million USD | -770.656% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 30.114% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -89.828% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 98.141% |
| Axonics, Inc. | 82.35 Million USD | 50.473% |
| Outset Medical, Inc. | 190.91 Million USD | 78.634% |
| IRIDEX Corporation | 24.91 Million USD | -63.724% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 67.095% |
| IRadimed Corporation | 20.73 Million USD | -96.713% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -2336.692% |
| INVO Bioscience, Inc. | 19.99 Million USD | -104.003% |
| Telesis Bio, Inc. | 40.87 Million USD | 0.203% |
| Varex Imaging Corporation | 668.6 Million USD | 93.899% |
| Quipt Home Medical Corp. | 136.29 Million USD | 70.072% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1041.944% |
| Pulmonx Corporation | 60.63 Million USD | 32.729% |
| Dynatronics Corporation | 11.78 Million USD | -246.263% |
| Modular Medical, Inc. | 2.27 Million USD | -1695.345% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -903.697% |
| Semler Scientific, Inc. | 6.27 Million USD | -550.562% |
| InMode Ltd. | 75.91 Million USD | 46.268% |
| Bruker Corporation | 2.83 Billion USD | 98.562% |
| Cytosorbents Corporation | 29.98 Million USD | -36.033% |
| DexCom, Inc. | 4.19 Billion USD | 99.028% |
| Align Technology, Inc. | 2.45 Billion USD | 98.337% |
| Viveve Medical, Inc. | 10.84 Million USD | -276.051% |
| ZimVie Inc. | 795.85 Million USD | 94.875% |
| Movano Inc. | 5.97 Million USD | -583.025% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 61.005% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -9491.36% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -241.11% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 93.617% |
| Profound Medical Corp. | 12.66 Million USD | -222.049% |
| Insulet Corporation | 1.85 Billion USD | 97.802% |
| enVVeno Medical Corporation | 2.43 Million USD | -1575.163% |
| Surmodics, Inc. | 65.82 Million USD | 38.03% |
| iCAD, Inc. | 8 Million USD | -409.814% |
| Nuwellis, Inc. | 6.78 Million USD | -501.626% |
| Biotricity, Inc. | 35.91 Million USD | -13.56% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 81.712% |
| Aethlon Medical, Inc. | 2.47 Million USD | -1545.0% |
| InspireMD, Inc. | 8.14 Million USD | -400.985% |
| PAVmed Inc. | 57.13 Million USD | 28.61% |
| BIOLASE, Inc. | 35.34 Million USD | -15.396% |
| Beyond Air, Inc. | 29.77 Million USD | -36.995% |
| FONAR Corporation | 57.45 Million USD | 29.008% |
| AxoGen, Inc. | 101.16 Million USD | 59.678% |
| Vivani Medical, Inc. | 25.03 Million USD | -62.926% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 53.54% |
| Inari Medical, Inc. | 209.32 Million USD | 80.513% |
| UFP Technologies, Inc. | 118.04 Million USD | 65.445% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -221.424% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -1766.136% |
| Tenon Medical, Inc. | 5.56 Million USD | -632.715% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -2192.874% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -131.314% |
| AdaptHealth Corp. | 3.15 Billion USD | 98.706% |
| Sintx Technologies, Inc. | 6.59 Million USD | -518.69% |
| NanoVibronix, Inc. | 2.68 Million USD | -1418.624% |
| Quanterix Corporation | 78.08 Million USD | 47.761% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1041.944% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -735.01% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 96.096% |
| TransMedics Group, Inc. | 568.84 Million USD | 92.829% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -144.516% |
| NeuroMetrix, Inc. | 1.33 Million USD | -2959.748% |
| Hyperfine, Inc. | 9.8 Million USD | -316.227% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 83.7% |
| Biomerica, Inc. | 2.66 Million USD | -1431.74% |
| Bone Biologics Corporation | 831.4 Thousand USD | -4806.198% |
| AVITA Medical, Inc. | 19.86 Million USD | -105.333% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -1966.706% |
| Silk Road Medical, Inc | 114.15 Million USD | 64.269% |